These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 21567297)
1. [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome]. Braicks O; Anneken K; Reichelt D; Schäbitz WR; Dziewas R; Evers S; Husstedt IW Nervenarzt; 2011 Oct; 82(10):1290-5. PubMed ID: 21567297 [TBL] [Abstract][Full Text] [Related]
2. Treatment of immigrants and residents suffering from neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome. Husstedt IW; Braicks O; Reichelt D; Oelker-Grueneberg U; Evers S Acta Neurol Belg; 2013 Dec; 113(4):391-5. PubMed ID: 23460392 [TBL] [Abstract][Full Text] [Related]
3. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy. Tan IL; McArthur JC Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069 [No Abstract] [Full Text] [Related]
4. High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana. Opintan JA; Awadzi BK; Biney IJK; Ganu V; Doe R; Kenu E; Adu RF; Osei MM; Akumwena A; Grigg ME; Fahle GA; Newman MJ; Williamson PR; Lartey M Trans R Soc Trop Med Hyg; 2017 Oct; 111(10):464-471. PubMed ID: 29373741 [TBL] [Abstract][Full Text] [Related]
5. [HIV and the central nervous system]. Moulignier A Rev Neurol (Paris); 2006 Jan; 162(1):22-42. PubMed ID: 16446621 [TBL] [Abstract][Full Text] [Related]
6. HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. ; Garvey L; Winston A; Walsh J; Post F; Porter K; Gazzard B; Fisher M; Leen C; Pillay D; Hill T; Johnson M; Gilson R; Anderson J; Easterbrook P; Bansi L; Orkin C; Ainsworth J; Phillips AN; Sabin CA Eur J Neurol; 2011 Mar; 18(3):527-34. PubMed ID: 21159073 [TBL] [Abstract][Full Text] [Related]
8. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy. Welch K; Morse A; AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. Sacktor N J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162 [TBL] [Abstract][Full Text] [Related]
10. An analysis of three opportunistic infections in an outpatient HIV clinic in Jamaica. Barrow G; Clarke TR; Carrington D; Harvey K; Barton EN West Indian Med J; 2010 Jul; 59(4):393-9. PubMed ID: 21355514 [TBL] [Abstract][Full Text] [Related]
11. Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score. Lanoy E; Guiguet M; Bentata M; Rouveix E; Dhiver C; Poizot-Martin I; Costagliola D; Gasnault J; Neurology; 2011 Feb; 76(7):644-51. PubMed ID: 21248274 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era. Christo PP; Greco DB; Aleixo AW; Livramento JA BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083 [TBL] [Abstract][Full Text] [Related]
13. [Neurological manifestations of the HIV infection]. Arendt G; Nolting T MMW Fortschr Med; 2005 Apr; 147 Spec No 1():75-7. PubMed ID: 16385884 [TBL] [Abstract][Full Text] [Related]
14. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. Miralles P; Berenguer J; García de Viedma D; Padilla B; Cosin J; López-Bernaldo de Quirós JC; Muñoz L; Moreno S; Bouza E AIDS; 1998 Dec; 12(18):2467-72. PubMed ID: 9875585 [TBL] [Abstract][Full Text] [Related]
16. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420 [TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. Post MJ; Yiannoutsos C; Simpson D; Booss J; Clifford DB; Cohen B; McArthur JC; Hall CD AJNR Am J Neuroradiol; 1999; 20(10):1896-906. PubMed ID: 10588116 [TBL] [Abstract][Full Text] [Related]
18. [The role of brain magnetic resonance studies in the diagnostics of central nervous system lesions in HIV-1 positive patients]. Sokolska V; Knysz B; Czapiga E; Gasiorowski J; Sasiadek M; Gładysz A Wiad Lek; 2006; 59(11-12):805-13. PubMed ID: 17427496 [TBL] [Abstract][Full Text] [Related]
20. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis. Wang F; So Y; Vittinghoff E; Malani H; Reingold A; Lewis E; Giordano J; Janssen R J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):75-82. PubMed ID: 8548350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]